Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N
Record ID 32010000166
English
Authors' recommendations:
Study found that continuous subcutaneous insulin infusion (CSII) provides some advantages over multiple daily injection (MDI) for both adults and children with type 1 diabetes mellitus, including better control of glucose levels, fewer problems with hypoglycaemia, and quality of life gains. However, there was no evidence that CSII is better than analogue-based MDI in type 2 diabetes mellitus or in gestational diabetes
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1622
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Infusions, Subcutaneous
- Insulin
- Insulin Infusion Systems
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen’s Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.